Studies in colorectal cancer have shown that low PIK3C2G copy numbers significantly increase recurrence and mortality risks (28), and in pancreatic cancer, PIK3C2G knockout in mouse models accelerated tumor progression, reduced survival, and increased drug resistance by disrupting mTORC1-mediated pathways (29). The gene discussed is PIK3C2G; the disease is pancreatic neoplasm.